United Kingdom · Series B startup

Who invested in Resolution Therapeutics

6 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Raised 5 months ago

Funding summaryUpdated 26 Oct 2026

$159Mraised across 6 rounds since 2022, from 6 sources

$4.1MSeries A$16MSeries A$19MSeries A$29MSeries B$68MSeries B$23MSeries B
Latest round
Series B, $23MMay 2026
Biggest round
$68MSeries B · Feb 2026
Investors
1
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20222023202420252026
$4.1MSeries A$16MSeries A$19MSeries A$29MSeries B$68MSeries B$23MSeries B
First round
Series A, $4.1M
Jan 2022
Biggest round
$68M
Series B · Feb 2026
Usual gap between rounds
10 months
the median of 5

The rounds

  1. May 2026
    Series B$23M

    No investor was named in the report.

    Shares issued, filed with Companies House (SH01); no report of this raise yet

  2. Feb 2026
    Series B$68M

    No investor was named in the report.

    Shares issued, filed with Companies House (SH01); no report of this raise yet

  3. Oct 2024
    Series B$29M1 new

    Source recorded

  4. Apr 2023
    Series A$19M

    No investor was named in the report.

    Shares issued, filed with Companies House (SH01); no report of this raise yet

  5. May 2022
    Series A$16M

    No investor was named in the report.

    Shares issued, filed with Companies House (SH01); no report of this raise yet

  6. Jan 2022
    Series A$4.1M

    No investor was named in the report.

    Shares issued, filed with Companies House (SH01); no report of this raise yet

Founders and team

From Resolution Therapeutics's own website: 14 on the team.

  • Amir HefniCEO
  • Amol KetkarChief Manufacturing and Technical Operations Officer
  • Daniel KennedyChief Business Officer
  • Lucy SingahChief Financial Officer
  • Eli GilsohnVP, Intellectual Property & Technology Strategy
  • Louise RoweVP, Operations
  • Shazia PandorVP, People & Culture
  • Alessio D'addabboAnalyst - Syncona
  • Bill SymondsNon-Executive Director
  • Edward HodgkinManaging Partner - Syncona
  • Gonzalo GarciaPrincipal - Syncona
  • Paul SekhriChair
  • Prof. John CampbellDirector - TCAT Scottish National Blood Transfusion Service
  • Prof. Jonathan FallowfieldChair of Translational Liver Research

Everyone who backed them

Missing a round, or an investor who was in one? Tell us.

Quick answers about Resolution Therapeutics

Who invested in Resolution Therapeutics?

Resolution Therapeutics's investors include Old College Capital Lp.

How much has Resolution Therapeutics raised?

Resolution Therapeutics has raised $159M across 6 rounds since 2022.

When did Resolution Therapeutics last raise?

Resolution Therapeutics's most recent round was a Series B of $23M in May 2026.

What was Resolution Therapeutics's biggest round?

Resolution Therapeutics's largest round on record is $68M (Series B), in Feb 2026.

Who backed Resolution Therapeutics first?

Resolution Therapeutics's first round on record, in Oct 2024, was backed by Old College Capital Lp.

What stage is Resolution Therapeutics at?

Resolution Therapeutics's latest named round is a Series B, in May 2026.

Where is Resolution Therapeutics based?

Resolution Therapeutics is based in the United Kingdom.

Companies like Resolution Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.